Manufacturer record
Rhombus Pharma Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Rhombus Pharma Pvt. Ltd (Gujarat) were declared Not of Standard Quality between March 2025 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LR25J006, Levocetirizine Dihydrochloride and Montelukast Syrup (exp Sep 2027). CDTL, Mumbai (CDSCO lab) found it not of standard quality: The sample received does not conform to I.P. 2022 with respect to the test for pH. Listed in the March 2026 alert.
Records by type
3 records linked to Rhombus Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride and Montelukast Syrup | Batch LR25J006Mfg Oct 2025 · Exp Sep 2027 | The sample received does not conform to I.P. 2022 with respect to the test for pHpH | CDTL, MumbaiCDSCO lab | Mar 2026 |
| Levocetirizine Dihydrochloride & Montelukast Tablets 11 | Batch TR25C042CMfg Mar 2025 · Exp Feb 2027 | The sample does not conmorm to the IP with respect to Assay of Lexncetirizine Dihydrochloride & MoptelukasAssay | DTL JodhpurState lab | Dec 2025 |
| Lactulose Solution U.S.P. (Reevac), 100 ml | Batch R23K015Mfg Nov 2023 · Exp Oct 2025 | "Organic impurities"Other | CDTL-MumbaiCDSCO lab | Mar 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.